Clinical Trials Directory

Trials / Unknown

UnknownNCT04091074

Safety and Effectiveness of Ticagrelor in Patients Undergoing Carotid Stenting

Status
Unknown
Phase
Phase 1
Study type
Interventional
Enrollment
26 (estimated)
Sponsor
Assiut University · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

patients undergoing carotid stenting take dual anti platelet therapy to prevent thrombotic complications usually used drugs are aspirin plus clopidogrel but there are patients not respond so ticagrelor may be an effective and safe alternative

Conditions

Interventions

TypeNameDescription
DRUGTicagrelorHalf of patients undergoing carotid stenting take ticagrelor+aspirin
DRUGClopidogrelOther half ofpatients undergoing carotid stenting take clopidogrel+aspirin
PROCEDURECarotid stentingPatients with carotid stenosis will undergo carotid stenting

Timeline

Start date
2022-01-01
Primary completion
2022-12-01
Completion
2022-12-01
First posted
2019-09-16
Last updated
2021-03-23

Source: ClinicalTrials.gov record NCT04091074. Inclusion in this directory is not an endorsement.